| ADHD medication use, adherence, persistence and cost among Texas Medicaid children JC Barner, S Khoza, A Oladapo Current medical research and opinion 27 (sup2), 13-22, 2011 | 99 | 2011 |
| Health‐related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials AO Oladapo, JD Epstein, E Williams, D Ito, A Gringeri, LA Valentino Haemophilia 21 (5), e344-e358, 2015 | 95 | 2015 |
| Review of survey articles regarding medication therapy management (MTM) services/programs in the United States AO Oladapo, KL Rascati Journal of pharmacy practice 25 (4), 457-470, 2012 | 57 | 2012 |
| The state of health economic research in South Africa: a systematic review P Gavaza, KL Rascati, AO Oladapo, S Khoza Pharmacoeconomics 30, 925-940, 2012 | 44 | 2012 |
| The state of health economic evaluation research in Nigeria: a systematic review P Gavaza, KL Rascati, AO Oladapo, S Khoza Pharmacoeconomics 28, 539-553, 2010 | 39 | 2010 |
| Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis A Oladapo, JC Barner, KA Lawson, S Novak, KL Rascati, KM Richards, ... Journal of Managed Care Pharmacy 20 (7), 657-667, 2014 | 31 | 2014 |
| A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid AO Oladapo, JC Barner, KL Rascati, SA Strassels Clinical therapeutics 34 (3), 605-613, 2012 | 27 | 2012 |
| Inhibitor clinical burden of disease: a comparative analysis of the CHESS data AO Oladapo, M Lu, S Walsh, J O’Hara, TL Kauf Orphanet Journal of Rare Diseases 13, 1-11, 2018 | 22 | 2018 |
| Real‐world comparative analysis of bleeding complications and health‐related quality of life in patients with haemophilia A and haemophilia B J Booth, A Oladapo, S Walsh, J O'Hara, L Carroll, DA Garcia Diego, ... Haemophilia 24 (5), e322-e327, 2018 | 20 | 2018 |
| Assessing the psychometric properties of smoking-related attitudes, self-efficacy, and intention among a diverse population of middle school students KH Ford, AO Oladapo, KL Sterling, PM Diamond, SH Kelder, A McAlister Addictive Behaviors 38 (8), 2378-2383, 2013 | 13 | 2013 |
| Effectiveness and safety of palivizumab for the prevention of serious lower respiratory tract infection caused by respiratory syncytial virus: a systematic review T Gonzales, A Bergamasco, T Cristarella, C Goyer, M Wojdyla, A Oladapo, ... American Journal of Perinatology, 2023 | 9 | 2023 |
| Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent … G Kenet, A Oladapo, JD Epstein, C Thompson, A Novack, DJ Nugent Haemophilia 23 (5), e394-e402, 2017 | 9 | 2017 |
| The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services AO Oladapo, JC Barner, KL Rascati Clinical therapeutics 34 (11), 2196-2199, 2012 | 9 | 2012 |
| A budget impact model of hemophilia bypassing agent prophylaxis relative to recombinant factor VIIa on-demand DA Mehta, AO Oladapo, JD Epstein, AR Novack, EJ Neufeld, JW Hay Journal of Managed Care & Specialty Pharmacy 22 (2), 149-157, 2016 | 8 | 2016 |
| Adherence to medication for attention deficit/hyperactivity disorder: does time frame matter? S Khoza, AO Oladapo, JC Barner Journal of Pharmaceutical Health Services Research 2 (3), 157-163, 2011 | 8 | 2011 |
| Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States M Lu, A Oladapo, Y Wu, S Farahbakhshian, B Ewenstein Journal of Managed Care & Specialty Pharmacy 27 (2), 175-185, 2021 | 7 | 2021 |
| Patient experience with congenital (hereditary) thrombotic thrombocytopenic purpura: a conceptual framework of symptoms and impacts AO Oladapo, D Ito, C Hibbard, SE Bean, RN Krupnick, BM Ewenstein The Patient-Patient-Centered Outcomes Research 12, 503-512, 2019 | 7 | 2019 |
| RSV-related hospitalization and outpatient palivizumab use in very preterm (born at< 29 wGA) infants: 2003-2020 ER Packnett, IH Winer, H Larkin, A Oladapo, T Gonzales, M Wojdyla, ... Human Vaccines & Immunotherapeutics 18 (6), 2140533, 2022 | 5 | 2022 |
| Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database JC Roberts, LM Malec, I Halari, SA Hale, A Oladapo, RF Sidonio Jr Haemophilia 28 (1), 97-108, 2022 | 4 | 2022 |
| Economic burden associated with major surgery in patients with von Willebrand disease: A United States retrospective administrative database analysis A Oladapo, Y Wu, M Lu, S Farahbakhshian, B Ewenstein Journal of Blood Medicine, 699-708, 2021 | 3 | 2021 |
